Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze XENE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate XENE investment potential.

What is XENE stock price today?

Get real-time XENE stock price, historical data, and price charts on Financhill. Track XENE performance with our advanced analysis tools.

Is XENE a good investment?

Evaluate XENE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy XENE stock?

To buy XENE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of XENE?

View detailed market capitalization data and company valuation metrics for XENE on our comprehensive analysis page.

What is the P/E ratio of XENE?

Use our fundamental analysis tools to view XENE P/E ratio and compare valuation metrics with industry peers.

What are XENE earnings?

View XENE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Xenon Pharmaceuticals, Inc. Stock Predictions

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

XENE
Xenon Pharmaceuticals, Inc.

Last Price:

$42.16

Seasonality Move:

-2.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

Xenon Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Xenon Pharmaceuticals, Inc. has on average historically risen by 25.4% based on the past 11 years of stock performance.
Xenon Pharmaceuticals, Inc. has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Is Xenon Pharmaceuticals, Inc. Stock Undervalued?

The current Xenon Pharmaceuticals, Inc. [XENE] share price is $42.15. The Score for XENE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
XENE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Xenon Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Xenon Pharmaceuticals, Inc. has on average historically risen by 25.4% based on the past 11 years of stock performance.

Xenon Pharmaceuticals, Inc. Stock Rating

Sell

Xenon Pharmaceuticals, Inc. (XENE) is a Sell

Is Xenon Pharmaceuticals, Inc. overpriced?

Xenon Pharmaceuticals, Inc. has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Xenon Pharmaceuticals, Inc. Stock Price History

Is XENE stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Canada

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

xenon-pharma.com

52-Week Data

52-Week High:

46.60

52-Week Low:

26.74

Prediction Charts

Market Cap:

3.3B

Price in USD:

42.15

Volume:

2.1M

Beta:

1.23

Technical Analysis

SMA50:

42.45

SMA100:

40.76

SMA200:

36.77

52-Wk Change:

6.57%

Stock Predictions

Is Xenon Pharmaceuticals, Inc. stock public?

Yes, Xenon Pharmaceuticals, Inc. is a publicly traded company.
What is the Xenon Pharmaceuticals, Inc. stock quote today?

The Xenon Pharmaceuticals, Inc. stock price is 42.15 USD today.
How to buy Xenon Pharmaceuticals, Inc. stock online?

You can buy Xenon Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-19	43.35	44.10	44.45	43.26
Dec-22	43.86	46.08	46.25	43.86
Dec-23	45.68	44.54	46.08	44.47
Dec-24	44.64	45.01	45.38	44.56
Dec-26	45.15	44.84	45.15	44.30
Dec-29	44.49	44.33	45.08	44.21
Dec-30	44.26	44.12	44.53	43.41
Dec-31	44.18	44.82	46.36	43.81
Jan-2	45.20	44.49	45.24	43.20
Jan-5	44.03	41.79	44.26	41.42
Jan-6	41.62	41.00	42.27	40.41
Jan-7	40.62	42.12	42.88	40.61
Jan-8	41.80	41.22	42.24	40.02
Jan-9	41.55	42.15	43.76	41.32

Xenon Pharmaceuticals, Inc. Earnings

Xenon Pharmaceuticals, Inc. Earnings Report: Per Share Xenon Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Xenon Pharmaceuticals, Inc. Forecast Revenue Growth

Xenon Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Xenon Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.09 per share.

* Xenon Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.